Skip to main content
Featured products
The OSYPKA PACE 300® is a three-chamber external pacemaker designed for temporary biventricular…
Quantum System for ECMO and extracorporeal perfusion: a modular platform for configuring…
Temporary myocardial pacing cables intended for use after cardiac surgery. Available in multiple…
The DynamX® coronary bioadaptor from Elixir Medical introduces pioneering technology to coronary…

    Spectrum Hybrid System

    The Spectrum Hybrid System is a sterile reservoir that combines the advantages of hardshell reservoirs and bag reservoirs in a compact design, optimising volume management and reducing the air-blood interface.

    Spectrum Hybrid System

    Spectrum Hybrid System
    Spectrum Hybrid System

    The Spectrum Hybrid System is a sterile reservoir that combines the advantages of hardshell reservoirs and bag reservoirs in a compact design, optimising volume management and reducing the air-blood interface.


    This system represents a fundamental innovation in extracorporeal perfusion. Its hybrid architecture sequesters excess volume efficiently, enabling stable operation even at very low levels. Thanks to its fully biocompatible construction with a phosphorylcholine coating and the incorporation of a dual-chamber cardiotomy module, the system significantly improves clinical safety and delivers superior antithrombotic performance compared with traditional reservoirs.

    Features

    • System with an operating volume from 150 ml to 4 L.
    • Hybrid architecture that safely integrates a rigid chamber and a venous bag.
    • Compatible with vacuum-assisted venous drainage (VAVD) protocols.
    • High-efficiency dual-chamber passive air handling.

    Hybrid technology and air-interface minimisation

    The hybrid design enables efficient vertical storage of excess blood. An exclusive internal membrane allows the safe use of VAVD and ensures level stability during rapid volume fluctuations. By featuring a narrower open section extending up to 1.5 L, the system drastically reduces air-blood exposure.

    Advanced air and activated blood management

    The system achieves superior gaseous microemboli (GME) removal at both low and high cardiotomy levels. For cellular protection, activated blood from field suction is collected in a separate cardiotomy chamber. This chamber features a dedicated port to transfer the blood to a cell saver. If the procedure requires it, opening a valve allows this blood to be integrated into the non-activated circuit.

    Maximum biocompatibility: Reduced contact surface area

    To mitigate the inflammatory response, the total blood-contact surface area is 2.8 times smaller compared with standard hardshell systems. The entire surface (12,255 cm² in total) is treated with phosphorylcholine to ensure comprehensive bioprotection throughout the procedure.

    Benefits

    • Greater haemodynamic stability: Slow level changes provide greater safety and reduce the risk of air entrainment.
    • Easy transition: Intuitive, user-friendly design for perfusionists accustomed to conventional hardshell systems.
    • Integrated precision: Features built-in volume measurement and positive and negative pressure valves.
    • Supports high venous flows without compromising circuit integrity.